Methyl 6-bromo-5-[4-[[1-(3-fluoropropyl)azetidin-3-yl]methyl]phenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate
C26H29BrFNO2 — CID 163262251
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 6-bromo-5-[4-[[1-(3-fluoropropyl)azetidin-3-yl]methyl]phenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate
Methyl 6-bromo-5-[4-[[1-(3-fluoropropyl)azetidin-3-yl]methyl]phenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate (PubChem CID 163262251) has the molecular formula C26H29BrFNO2 and a molecular weight of 486.43 g/mol. Its IUPAC name is methyl 6-bromo-5-[4-[[1-(3-fluoropropyl)azetidin-3-yl]methyl]phenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate.
Molecular Properties
| Compound Name | Methyl 6-bromo-5-[4-[[1-(3-fluoropropyl)azetidin-3-yl]methyl]phenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate |
|---|---|
| PubChem CID | 163262251 |
| Molecular Formula | C26H29BrFNO2 |
| Molecular Weight | 486.43 g/mol |
| Exact Mass | 485.14 |
| IUPAC Name | methyl 6-bromo-5-[4-[[1-(3-fluoropropyl)azetidin-3-yl]methyl]phenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate |
| SMILES | COC(=O)c1ccc2c(c1)CCCC(Br)=C2c1ccc(CC2CN(CCCF)C2)cc1 |
| InChI | InChI=1S/C26H29BrFNO2/c1-31-26(30)22-10-11-23-21(15-22)4-2-5-24(27)25(23)20-8-6-18(7-9-20)14-19-16-29(17-19)13-3-12-28/h6-11,15,19H,2-5,12-14,16-17H2,1H3 |
| InChIKey | WATRJHBITORRAM-UHFFFAOYSA-N |
| XLogP | 5.80 |
| TPSA | 29.54 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.43 |
| LogP ≤ 5 | 5.80 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163262251 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.